Sort
23,748 grants matching “melanoma”
Mechanistic, prognostic, and therapeutic impact of the mitochondrial fission GTPase DRP1 in melanoma
$192,000Madhavika Niroshini Serasinghe · Icahn School Of Medicine At Mount Sinai · K22 · FY2019 · CA
Mechanistic, prognostic, and therapeutic impact of the mitochondrial fission GTPase DRP1 in melanoma
$192,000Madhavika Niroshini Serasinghe · Icahn School Of Medicine At Mount Sinai · K22 · FY2018 · CA
Mechanistic, prognostic, and therapeutic impact of the mitochondrial fission GTPase DRP1 in melanoma
$192,000Madhavika Niroshini Serasinghe · Icahn School Of Medicine At Mount Sinai · K22 · FY2017 · CA
CELLULAR PROTEIN MATURATION AND DEGRADATION
$191,940University Of Massachusetts Amherst · R01 · FY2001 · CA
MOLECULAR EPIDEMIOLOGY OF GENETIC MARKERS IN MELANOMA
$191,918University Of Texas Md Anderson Can Ctr · P50 · FY2005 · CA
MOLECULAR EPIDEMIOLOGY OF GENETIC MARKERS IN MELANOMA
$191,918Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2006 · CA
MOLECULAR EPIDEMIOLOGY OF GENETIC MARKERS IN MELANOMA
$191,918University Of Texas Md Anderson Can Ctr · P50 · FY2004 · CA
Analytic and Clinical Validation of a 7-plex MIF Assay for Predictive Response of Advanced NSCLC to Anti-PD-1 based Therapy
$191,915Janis M. Taube · Johns Hopkins University · UH2 · FY2023 · CA
Identifying recurrent driver mutations in skin cancers by targeted UV damage sequencing
$191,875John J Wyrick · Washington State University · R21 · FY2024 · ES
Delivering miR-29a to enhance anti-viral and anti-tumor responses in vivo
$191,875Erietta Stelekati · University Of Miami School Of Medicine · R21 · FY2024 · AI
Targeting PRMT5 to combat cancer drug resistance associated with neuroendocrine differentiation
$191,875Jingwei Cheng · University Of New Hampshire · P20 · FY2023 · GM
UV damage stimulation by ETS transcription factors in skin cancer
$191,850John J Wyrick · Washington State University · R21 · FY2020 · ES
MATCHMAKERS: Large-scale generation of TCR-pMHC pairs from naturally occurring sources.
$191,844Dirk Busch · Technical University Of Munich · OT2 · FY2024 · CA
Raf Kinase Inhibitory Protein (RKIP): A New Hepatocellular Carcinoma Tumor Suppre
$191,824John M. Sedivy · Brown University · R21 · FY2009 · CA
Docking DRibbles to dendritic cells via C-type lectin receptors
$191,796Hong-Ming Hu · Providence Portland Medical Center · R21 · FY2010 · CA
CANCER AND LEUKEMIA GROUP B (CALGB)
$191,731Dartmouth College · U10 · FY2002 · CA
Optical imaging of primary and regional melanoma to guide surgical resection
$191,672Eben L Rosenthal · University Of Alabama At Birmingham · R21 · FY2013 · CA
OHSU Knight Cancer Institute
$191,618Thomas A Sellers · Oregon Health & Science University · P30 · FY2024 · CA
OHSU Knight Cancer Institute
$191,618Brian J Druker · Oregon Health & Science University · P30 · FY2023 · CA
Role of Sirt2 in T Cell Metabolism
$191,611Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2023 · CA
Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition
$191,520Maria De Los Angeles Lopez-Olivo · University Of Tx Md Anderson Can Ctr · K08 · FY2023 · CA
Epidemiology of MGUS in Southeastern Minnesota
$191,505S Vincent Rajkumar · Mayo Clinic Rochester · P01 · FY2007 · CA
Molecular Imaging in the Treatment of Kaposi's Sarcoma
$191,503Richard F. Ambinder · Johns Hopkins University · P50 · FY2013 · CA
Smartphone confocal microscopy for diagnosing Kaposiâs sarcoma
$191,494Dongkyun Kang · Massachusetts General Hospital · R21 · FY2016 · TW
VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESIS
$191,474Massachusetts General Hospital · R01 · FY2001 · CA